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Abstract: Nailfold capillaroscopy is currently the best method to investigate microvascular abnormalities in systemic 
sclerosis and related conditions, and in other rheumatic conditions in which there is a clinical suspicion of 
microangiopathy. Although easy to perform, it is essential that the operators have been properly trained about correct 
method of images acquisition and interpretation. There are some parameters to indicate a normal/healthy capillaroscopic 
picture, but it is important to consider that there is a great variability in the capillary structure both interindividual and 
intraindividual. The early differential diagnosis between primary and secondary RP is the best advantage that the 
technique may offer. 
Remarkable capillaroscopic alterations are found in the majority of cases of systemic sclerosis and the so-called 
“scleroderma spectrum disorders” (dermatomyositis, mixed connective tissue disease, undifferentiated connective tissue 
disease). Nevertheless, some capillaroscopic changes have been observed in systemic lupus erythematosus, Sjogren’s 
syndrome, psoriatic and rheumatoid arthritis. 
Discussion about controversies on this topic should be encouraged, leading to a progressive development of 
capillaroscopy as a routine investigation in rheumatology. 
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Capillaroscopy represents a "non-invasive" method 
of investigation of undisputed value in the recognition 
of morphological and functional microcirculatory 
abnormalities. Its use dates back to the beginning of 
the 20th century, but it was confined mainly to the 
experimental field until the 1980s. Since then, clinical 
applications of capillaroscopy have gradually 
expanded, especially in the field of rheumatology, to 
become an essential first-level examination for the 
differential diagnosis of primary and secondary 
Raynaud's phenomenon. The latter refers to a clinical 
manifestation that implies the presence of an 
underlying systemic disease. Among the diseases of 
rheumatologic interest, the more strongly linked to 
Raynaud’s phenomenon is systemic sclerosis, even if it 
may appear also with other autoimmune diseases such 
as systemic lupus erythematosus, dermatomyositis, 
undifferentiated/mixed connective tissue disease.  
The “in vivo” study of microcirculation takes place 
mainly at nailfold skin level. This is due to the fact that 
the major axis of the capillaries is parallel to the skin 
surface in this area, while in other areas, capillaries run 
perpendicular to the skin [1, 2]. 
Nailfold capillaroscopy can be carried out with 
various types of optical device, ranging from a simple 
magnifying glass to devices like the video 
 
 
*Address correspondence to this author at the Clinica Reumatologica, 
Università “Politecnica delle Marche”, via Aldo Moro, 25 Jesi (Ancona), 60035, 
Italy; Tel: ++39 0731 534125; Fax: ++39 0731 534124;  
E-mail: r.deangelis@staff.univpm.it 
capillaroscope with optical contact probes. The use of 
an ophthalmoscope or a dermatoscope represents the 
simplest method for a general and immediate 
assessment of the nailfold margin, albeit of low 
sensitivity due to the limited level of magnification (20x) 
[2,3]. A reflex camera equipped with good lenses offers 
an adequate panoramic view, while the 
stereomicroscope and the transmitted light optical 
microscope, with magnifications ranging from 10x to 
100x, and ensure general observation and 
simultaneous analysis of detail of the single loops [2, 
3]. In recent years, videocapillaroscopy with optical 
probes has opened new and original perspectives in 
the study of microcirculation, for the possibility of 
exploring both nailfold and non-nailfold skin [4]. The 
instrument can be equipped with software that uses 
algorithms for storing images and allow immediate 
printing for reporting.  
Capillaroscopic examination must be performed on 
all fingers, correctly positioned with respect to the 
surface of the lens. The application of a drop of cedar 
oil on the skin to be explored makes it possible to 
obtain the best conditions of visibility of the capillaries. 
The examination should be carried out after a phase of 
"acclimatization" of variable duration, in relation to the 
difference between outdoor temperature and room 
temperature [1, 2]. 
The main parameters to be analyzed during 
capillaroscopic examination are skin transparency, 
visibility of the sub-papillary venous plexus, density, 
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direction and spatial distribution of the loops, length 
and diameter of the capillaries, and flow characteristics 
[2, 3]. 
THE HEALTHY SUBJECT 
In healthy subjects, the capillaroscopic picture is 
generally characterized by the morphological 
homogeneity of diameter, orientation and distribution of 
the capillaries, which look like an "inverted U" or 
"hairpin", arranged in a "comb" pattern, with a major 
axis running parallel to the skin surface (Figure 1). The 
number of capillaries varies between 9 and 13 per mm 
and the morphological and structural characteristics of 
the nailfold microcirculation remain constant over time 
[2, 3]. The morphology of the capillaries and the 
architecture of the microvascular network can be very 
different among subjects, and this depends on several 
factors (age, gender, race, work activity), and even 
within the same individual, from finger to finger. 
 
Figure 1: Healthy subject: nailfold capillaroscopic pattern. 
Isolated abnormalities of distribution, morphology 
and orientation are not uncommon in the healthy 
subject, and their presence can be related to a wide 
range of conditions such as manicure, onychophagy, 
microtrauma and manual activities [2, 3]. Based on a 
cluster analysis, three morphologic patterns were 
described [5]:  
1) the classic “normal pattern”, mainly with 2 to 5 U-
shaped loops/mm and ≤ 2 tortuous loops/mm; 2) the 
“perfect normal” pattern with ≥ 5 U-shaped loops/mm; 
3) the “unusual normal” with at least 1 meandering or 
bushy loop, or at least 1 microhaemorrhage, or with 4 
crossed loops/mm.  
Instead, if there is a microcirculatory impairment, 
there are marked alterations in the main capillaroscopic 
parameters, with significant changes in the orientation, 
morphology and spatial distribution of the loops that 
contribute to the disarrangement of the normal capillary 
architecture [3, 4]. 
THE SCLERODERMA MICROANGIOPATHY 
The complex of alterations of the nailfold capillary 
network characteristic of systemic sclerosis and of the 
group of "scleroderma spectrum disorders" is called 
“scleroderma pattern”. There are various types of 
capillaroscopic expression regarding the scleroderma 
microangiopathy and these may coexist or manifest 
alone. Architectural disorder, the presence of 
homogeneous and/or uneven ectasias, 
microhemorrhages, marked expressions of capillary 
neoformation, and the reduction of the number of 
capillaries through to the appearance of avascular 
areas (no capillaries within an area > 500 microns) are 
the main elements that characterize the scleroderma 
microangiopathy (Figure 2A-D) [6]. 
The scleroderma pattern can be observed in more 
than 90% of patients with systemic sclerosis, in about 
75% of patients with dermatomyositis, in more than 
50% of patients with mixed connective tissue and, to a 
lesser extent, in patients with undifferentiated 
connective tissue disease and with Sjögren's syndrome 
[2-5] (Table 1). 
Architectural derangement is an almost constant 
expression and its characteristics vary according to the 
stage of the diseases. In the early stages, it is 
characterized above all by the occurrence of normal 
capillaries alternating with regular and irregular dilated 
loops (Figure 3). In the most aggressive forms, 
avascular areas and anarchic capillary neoformation 
accentuate the architectural disorder even more, 
creating situations that can be considered typical of the 
scleroderma microngiopathy (Figure 4). 
Based on the characteristics of the nailfold 
capillaroscopic pattern, the fundamental role of 
capillaroscopy in predictive assessment of the course 
of the disease has often been valued. The forms 
characterized by the presence of a marked increase in 
capillary diameter (microaneurysmatic ectasias, 
megacapillaries and irregular ectasias), without 
avascular areas, are typical of variants of the disease 
with a poorly evolving imprint, while the appearance of 
avascular areas characterizes the more aggressive 
forms [6].  
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Figure 2: Specific capillary abnormalities of the scleroderma pattern: relevant architectural derangement with enlarged loops, 
branching capillaries, microbleedings and loss of capillaries. 
 
Table 1: Capillaroscopic Abnormalities and Frequency of the “Scleroderma Pattern” in Connective Tissue Diseases 
 Capillaroscopic pattern Main abnormalities 
% of patient’s 
population with 
scleroderma pattern 
Primary RP Normal / / 
Systemic sclerosis Scleroderma pattern 
Megacapillaries, irregular enlarged loops, 
microhaemorrhages, reduction in capillary 
density, avascular areas 
>90 
Dermatomyositis Scleroderma pattern Megacapillaries, irregular enlarged loops, micro-haemorrhages, neoangiogenesis ~70 
Mixed connective tissue disease Scleroderma pattern Megacapillaries, irregular enlarged loops, microhaemorrhages, avascular areas ~50 
Undifferentiate connective tissue 
disease Scleroderma pattern Megacapillaries, irregular enlarged loops 10-20 
Sjögren’s syndrome If there is an overlap syndrome 
Megacapillaries, irregular enlarged loops, 
reduction in capillary density < 5 
Systemic lupus erythematosus If there is an overlap syndrome 
Megacapillaries, irregular enlarged loops, 
reduction in capillary density < 5 
RP= Raynaud’s phenomenon. 
CAPILLAROSCOPY IN RHEUMATOLOGICAL 
DISEASES  
Raynaud's Phenomenon 
Nailfold capillaroscopy can be considered the first 
method used for the differential diagnosis between 
"primary" and "secondary" Raynaud’s phenomenon.  
In a patient with a clinically isolated Raynaud’s 
phenomenon, the presence of one or more of the 
specific abnormalities of the scleroderma 
microangiopathy, even when limited to a single finger, 
should be considered indicative of a secondary nature, 
and justifies the simultaneous performance of further 
investigations, such as the detection of anti-nuclear 
antibodies [6].  
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Capillaroscopic findings allow significant 
stratifications of the risk of evolution towards a 
"scleroderma spectrum disorder" within five years in 
subjects with isolated Raynaud’s phenomenon, using a 
composite algorithm based on the presence of 
megacapillaries, microhemorrhages and the number of 
capillaries/mm [7]. The association of capillaroscopic 
abnormalities typical of the scleroderma pattern with 
the positivity of "specific" antinuclear antibodies (anti-
centromere or anti-topoisomerase I) makes it possible 
to develop an additional predictive model capable of 
distinctly assessing the evolution towards systemic 
sclerosis [8]. 
Systemic Sclerosis 
In scleroderma patients, a significant association 
between the severity of the skin involvement and/or 
 
Figure 3: Scleroderma pattern: homogeneusly and inhomogeneusly marked enlarged loops.  
 
 
Figure 4: Scleroderma pattern: low skin transparency, loss of capillaries, avascular areas delimited by loops with relevant shape 
heterogeneity. 
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internal organs and capillaroscopic findings has been 
demonstrated. Patients with large avascular areas 
have an increased risk of "active" disease, of 
developing digital ulcers and of presenting a more 
significant skin, lung and cardiac involvement [9]. 
Capillaroscopy during systemic sclerosis is also 
used for prognostic purposes to identify patients with a 
high risk of developing digital ulcers or pulmonary 
arterial hypertension. In particular, the "quantitative" 
analysis of the single abnormalities at nailfold level 
(number of megacapillaries, maximum capillary 
diameter, and total number of capillaries) allows the 
construction of a highly specific and sensitive 
prognostic index capable of predicting the occurrence 
of digital ulcers [10]. 
Dermatomyositis 
Dermatomyositis differs from polymyositis due to 
the substantial involvement of the microcirculation at 
skin and muscle level, and to the detection of 
capillaroscopic nailfold alterations in about 2/3 of 
subjects. Raynaud's phenomenon is frequent, in 
association with capillaroscopic nailfold abnormalities 
that can be similar on those of patients with systemic 
sclerosis (megacapillaries, irregular ectasies, 
microhemorrhages, neoangiogenesis, and 
derangement of microvascular architecture). 
Expressions of flourishing neoangiogenesis are 
frequently observed and may in some cases constitute 
the dominant capillaroscopic abnormality (Figure 5). In 
patients with dermatomyositis, a particular 
microcirculatory environment has also been described, 
characterized by rapid changes in the morphology of 
the capillaries, which follow on from one another within 
the space of even just a few days [11, 12]. 
Mixed Connective Tissue Disease 
The capillaroscopic pattern of mixed connective 
tissue disease can be very different, with expressions 
falling within the normal range or within manifest 
pathological pictures. Capillaroscopic alterations similar 
to those of scleroderma microangiopathy are 
detectable in more than half of all patients [13]. The 
presence of avascular areas is associated with 
pulmonary interstitial disease [13] and the detection of 
a scleroderma pattern seems to predict the 
development of pulmonary arterial hypertension. 
Undifferentiated Connective Tissue Disease 
Undifferentiated connective tissue disease is a 
condition in which there are signs and/or symptoms of 
systemic autoimmune disease that do not meet the 
classification and/or diagnostic criteria for "major" 
connective tissue disease. In most subjects, the 
capillaroscopic picture is normal. In some patients, 
especially if Raynaud’s phenomenon is associated, it is 
possible to observe non-specific signs of 
microangiopathy, with a predominance of tortuous 
capillaries, homogeneous and inhomogeneous 
ecstasies [14]. In these cases, a capillaroscopic follow-
 
Figure 5: Dermatomyositis: architectural derangement of the nailfold capillary network with features of extreme angiogenesis. 
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up seems appropriate in order to identify a possible 
evolution towards a major connective tissue disease, 
such as systemic sclerosis [15]. Some characteristic 
abnormalities of the scleroderma pattern can be 
observed in association with the simultaneous 
presence of anti-RNP antibodies and Raynaud's 
phenomenon [14]. 
Systemic Lupus Erythematosus 
The capillaroscopic picture in patients with systemic 
lupus erythematosus is generally similar to that of the 
healthy subject. In about 1/3 of the patients, 
capillaroscopic abnormalities of uncertain significance 
have been described, including increased tortuosity, 
with loops that in some cases take on a meandering 
appearance, an increase in the length of the loops and 
greater visibility of the sub-papillary venous plexus [2, 
3]. A well-recognized scleroderma pattern, on the other 
hand, is observed only in a small number of patients 
(5%), associated with Raynaud's phenomenon and 
anti-RNP antibodies [16]. 
Sjögren's Syndrome 
In patients with Sjögren's syndrome, capillaroscopic 
alterations are unusual and, when present, are 
generally considered non-specific [17]. Some authors 
have observed reduced capillary density in presence of 
Raynaud's phenomenon or systemic manifestations of 
the disease. The presence of a scleroderma pattern is 
predictive of a possible evolution towards an "overlap" 
syndrome with systemic sclerosis [18]. 
Rheumatoid Arthritis 
Patients with rheumatoid arthritis show no 
characteristic or representative alterations of 
microvascular damage. In most cases, capillaroscopic 
findings are similar to those of the healthy subject [19]. 
Sometimes, it is possible to observe thin and elongated 
loops, together with a marked visibility of the sub-
papillary venous plexus, regarded in the past as a 
distinctive characteristic of a "rheumatoid" pattern. 
Now, these abnormalities are to be considered non-
specific and by some as the probable expression of a 
concomitant steroid therapy [2, 3]. 
Psoriatic Arthritis 
Nailfold capillaroscopy during psoriatic arthritis may 
reveal a series of non-specific abnormalities such as 
 
Figure 6: Capillaroscopy at the level of psoriatic plaque: 
tortuous, coiled balls, branching loops.  
 
Figure 7: A simple algorithm for differential diagnosis of Raynaud’s phenomenon. 
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microhemorrhages and reduction of capillary length 
("dwarf" loops), the latter probably linked to a reduction 
in visibility secondary to hyperkeratosis [2, 3]. In the 
areas of the skin where psoriasis occurs, capillaries 
with a convoluted (ball-like) appearance are evident 
(Figure 6), indicating a marked neoangiogenesis [20]. 
These alterations are reversible and may regress with 
the disappearance of psoriatic lesions [21]. 
CONCLUSIONS 
Capillaroscopy is fundamental in distinguishing 
between primary and secondary Raynaud’s 
phenomenon and has a prognostic value when 
combined with the presence of anti-nuclear antibodies 
(Figure 7). The inclusion of capillaroscopic alterations 
in the classification criteria of systemic sclerosis has 
increased its sensitivity and allowed to identify early 
and incomplete forms of the disease [22]. In patients 
belonging to the scleroderma spectrum group 
(dermatomyositis, mixed connective tissue disease, 
undifferentiated connective tissue disease) the 
capillaroscopic picture may present great differences, 
and may fall within the normal range up to clearly 
pathological pictures. In patients with diseases not 
belonging to the group of scleroderma spectrum 
(systemic lupus erythematosus, Sjogren’s syndrome), 
the presence of abnormalities typical of the 
scleroderma pattern must alert the clinician to the 
possibility of a full overlap with systemic sclerosis. In 
chronic arthritis (rheumatoid arthritis, psoriatic arthritis) 
the picture is mainly non-specific. 
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